Enzymotec Ltd. to Participate in the 16th Annual ICR XChange Conference
January 06 2014 - 3:05PM
Enzymotec Ltd. (Nasdaq:ENZY) ("Enzymotec"), a developer,
manufacturer and marketer of innovative bio-functional lipid
ingredients, announced today that Dr. Ariel Katz, President and
Chief Executive Officer, and Oren Bryan, Chief Financial Officer,
will present at the 16th Annual ICR XChange Conference on Monday,
January 13, 2014 at 10:00 a.m. ET in Orlando, FL.
The audio portion of Enzymotec's presentation will be webcast
live, and a replay will be available on the Investors section of
the Company's website at www.enzymotec.com.
About Enzymotec Ltd.
Enzymotec is a leading global supplier of specialty lipid-based
products and solutions. The Company develops, manufactures and
markets innovative bio-functional lipid ingredients, as well as
final products, based on sophisticated processes and technologies.
For more information, visit www.enzymotec.com.
CONTACT: ICR, LLC
Katie Turner
646-277-1228
-or-
John Mills
310-954-1105
John.Mills@icrinc.com
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Enzymotec Ltd. - Ordinary Shares (delisted) (NASDAQ): 0 recent articles
More News Articles